A. Van Oosterhout (Groningen, Netherlands)
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
M. Spears, C. McSharry, R. Chaudhuri, K. Nocka, G. Miele, W. T. Lee, M. Shepherd, N. Thomson (Glasgow, Manchester, United Kingdom; Cambridge, United States Of America)
|  |
Pre-clinical characterization of RP3128, a novel and potent CRAC channel inhibitor for the treatment of respiratory disorders
S. Vakkalanka, G. Merikapudi, G. Babu, K. Routhu, S. Veeraraghavan, S. Viswanadha (La Chaux-de-Fonds, Switzerland; Hyderabad, India)
|  |
Bitter taste receptors are expressed and induce relaxation of human bronchi
S. Grassin-Delyle, C. Abrial, S. Taleb-Fayad, M. Brollo, E. Naline, P. Devillier (Suresnes, France)
| |
Comparison of fluticasone, roflumilast and tiotropium in a model of influenza-induced acute COPD exacerbation
M. Duechs, E. Wex, L. Wollin, M. Pieper, F. Gantner, B. Jung (Biberach a.d. Riss, Germany)
| |
The anti-inflammatory effects of PF03715455 and roflumilast on both cellular and tissue inflammation in a mouse model of COPD
V. Russell, M. Foster, P. Woodman, A. Young (Slough, United Kingdom)
| |
Inhibition of phosphodiesterase 4B enhances glucocorticoid-dependent gene transcription in human airway epithelial cells: Implications for the treatment of COPD
P. Sharma, S. Wilson, R. Newton, M. Giembycz (Calgary, Canada)
| |
Combination study of tiotropium and olodaterol in human precision-cut lung slices
M. Schlepütz, N. Maihöfer, A. D. Rieg, S. Westphal, A. Perez-Bouza, T. Braunschweig, T. Schröder, J. W. Spillner, R. Autschbach, M. P. Pieper, S. Uhlig, C. Martin (Aachen, Bonn, Biberach an der Riß, Germany)
| |
A comparison of beta2-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
R. Lewis, L. Chachi, Y. Amrani, P. Bradding (Leicester, United Kingdom)
| |
Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy
D. Li, T. Yang, Y. Shen, S. Guo, F. Wen (Chengdu, China)
| |
Dehydroepiandrosterone in the treatment of steroid resistant asthma: Whether synthetic nanoform can replace the natural hormone?
G. Shmarina, A. Pukhalsky, A. Utekhina, G. Sergeev, O. Kozyreva, T. Vylegzhanina, V. Alioshkin (Moscow, Russian Federation)
| |
The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma
B. Leaker, B. O'Connor, P. Barnes, L. Mckenzie, D. Chernoff, J. Neville, P. Tam, G. Stenton, C. Harwig, T. MacRury (London, United Kingdom; Vancouver, Canada)
| |
Efficacy and safety of AZD5069, a CXCR2 antagonist, in adult bronchiectasis
I. Pavord, A. De Soyza, J. S. Elborn, D. Smith, H. Wray, M. Puu, B. Larsson, R. Stockley (Leicester, Newcastle upon Tyne, Belfast, Bristol, Birmingham, United Kingdom; Mölndal, Sweden)
| |
Urge to cough is significantly abolished by nasal thymol application
S. Gavliakova, Z. Biringerova, E. Hanuskova, T. Buday, I. Poliacek, J. Plevkova (Martin, Slovakia)
| |
Chinese herbs in treatment of postinfectious cough: A multi-centre, randomized, double-blind, placebo-controlled trial
H. Jiang, B. Mao, R. Zhang, Y. Xu, J. Ma, Q. Liu, F. Jin (Chengdu, Shenyang, Nanjing, Baotou, Xian, China)
| |
Penetration and pharmacokinetics of peramivir in upper and lower airway epithelia and plasma
Y. Funatsu, N. Hasegawa, H. Namkoong, T. Asami, H. Fujiwara, Y. Kimizuka, S. Tasaka, M. Ishii, F. Saito, K. Yagi, S. Iwata, T. Betsuyaku (Tokyo, Japan)
| |
Eliminating in-vitro drug-drug interactions in dual and triple fixed-dose combination therapies using a novel cosuspension metered dose inhaler platform
D. Lechuga-Ballesteros, V. Joshi, B. Noga, J. Howland, H. Cummings, R. Schultz, C. Orevillo, C. Reisner, S. Dwivedi (Redwood City, United States Of America)
| |
Intratracheal administration of dry powdered low-molecular-weight chitosan/siRNA complexes suppressed gene expression in the airway, alveoli, and metastatic tumors in murine lung
D. Ihara, N. Hattori, H. Okamoto, N. Kohno (Hiroshima, Nagoya, Japan)
| |
DEAE-dextran MMA copolymer non-viral vector for aerosol therapy in respiratory diseases
K. Darwiche, P. Zarogoulidis, C. Ritzoulis, W. Hohenforst-schmidt, L. Sakkas, A. Cheva, A. Sakkas, D. Spyratos, D. Sparopoulou, K. Zarogoulidis (Essen, Coburg, Germany; Thessaloniki, Greece)
| |